Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade
Zia Khan (),
Christian Hammer,
Jonathan Carroll,
Flavia Nucci,
Sergio Ley Acosta,
Vidya Maiya,
Tushar Bhangale,
Julie Hunkapiller,
Ira Mellman,
Matthew L. Albert,
Mark I. McCarthy and
G. Scott Chandler ()
Additional contact information
Zia Khan: Genentech
Christian Hammer: Genentech
Jonathan Carroll: Genentech
Flavia Nucci: Genentech
Sergio Ley Acosta: Genentech
Vidya Maiya: Genentech
Tushar Bhangale: Genentech
Julie Hunkapiller: Genentech
Ira Mellman: Genentech
Matthew L. Albert: Genentech
Mark I. McCarthy: Genentech
G. Scott Chandler: F. Hoffmann-La Roche
Nature Communications, 2021, vol. 12, issue 1, 1-12
Abstract:
Abstract Activation of systemic immune responses using PD-1 checkpoint inhibitors is an essential approach to cancer therapy. Yet, the extent of benefit relative to risk of immune related adverse events (irAE) varies widely among patients. Here, we study endocrine irAE from 7 clinical trials across 6 cancers where atezolizumab (anti-PD-L1) was combined with chemotherapies and compared to standard of care. We show that atezolizumab-induced thyroid dysfunction is associated with longer survival. We construct a polygenic risk score (PRS) for lifetime risk of hypothyroidism using a GWAS from the UK Biobank and apply this PRS to genetic data collected from 2,616 patients of European ancestry from these trials. Patients with high PRS are at increased risk of atezolizumab-induced thyroid dysfunction and lower risk of death in triple negative breast cancer. Our results indicate that genetic variation associated with thyroid autoimmunity interacts with biological pathways driving the systemic immune response to PD-1 blockade.
Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/s41467-021-23661-4 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23661-4
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-021-23661-4
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().